Wszystkie zdjęcia(1)



MISSION® pLKO.1-puro TurboGFP shRNA Control Plasmid DNA

shRNA sequence targeting tGFP

MISSION Control Vectors
Numer MDL:

linia produktu



500 ng/μL in TE buffer; DNA (10μg of plasmid DNA)


dry ice

temp. przechowywania


Szukasz podobnych produktów? Visit Przewodnik dotyczący porównywania produktów

Opis ogólny

The MISSION TurboGFP shRNA Control Vector is a 7,087 base pair lentivirus plasmid vector that contains an shRNA sequence targeting TurboGFP. The TurboGFP shRNA Control Vector is useful as a positive knockdown control in experiments using the MISSION TurboGFP positive control vector or in cell lines expressing TurboGFP. TurboGFP is an improved variant of the green fluorescent protein copGFP cloned from copepoda Pontellina plumata.
Ampicillin and puromycin antibiotic resistance genes provide selection in bacterial or mammalian cells respectively. In addition, self-inactivating replication incompetent viral particles can be produced in packaging cells (HEK293T) by co-transfection with compatible packaging plasmids. The TurboGFP shRNA Control Vector is provided as 10 μg of plasmid DNA in Tris-EDTA (TE) buffer at a concentration of 500 ng/μl.


To see more application data, protocols, vector maps visit
MISSION® pLKO.1-puro TurboGFP shRNA control plasmid DNA has been used as lentiviral transduction and RNA interference assay.

Informacje prawne

Use of this product is subject to one or more license agreements. For details, please see
MISSION is a registered trademark of Sigma-Aldrich Co. LLC
TurboGFP is a trademark of Evrogen Co.

Kod klasy składowania

12 - Non Combustible Liquids



Temperatura zapłonu °F

Not applicable

Temperatura zapłonu °C

Not applicable

Certyfikat analizy

Wprowadź numer partii, aby wyszukać certyfikat analizy (COA).

Świadectwo pochodzenia

Wprowadź numer partii, aby wyszukać świadectwo pochodzenia (COO).

SMCHD1 regulates a limited set of gene clusters on autosomal chromosomes
Mason A G, et al.
Skeletal Muscle, 7(1), 12-12 (2017)
Blocking Hedgehog release from pancreatic cancer cells increases paracrine signaling potency.
Damhofer H, et al.
Journal of Cell Science, 128(1), 129-139 (2015)
Lorraine Springuel et al.
Cellular and molecular life sciences : CMLS, 73(24), 4739-4748 (2016-07-21)
Genomic instability drives cancer progression by promoting genetic abnormalities that allow for the multi-step clonal selection of cells with growth advantages. We previously reported that the IL-9-dependent TS1 cell line sequentially acquired activating substitutions in JAK1 and JAK3 upon successive
Ze-Qiang Ren et al.
Pathology oncology research : POR, 26(2), 1153-1163 (2019-06-09)
Cullin-1 (CUL1) is an important factor for tumor growth and a potential therapeutic target for breast cancer therapy, but the molecular mechanism in triple-negative breast cancer (TNBC) is unknown. In the present study, CUL1 shRNA was transfected into BT549 and
The MEK2-binding tumor suppressor hDlg is recruited by E-cadherin to the midbody ring
Gaudet S, et al.
BMC Cell Biology, 12(1), 55-55 (2011)

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej